Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robin Swartz currently holds 199,738 shares of Voyager Therapeutics, Inc. (VYGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robin Swartz has been a net seller of VYGR stock. They have purchased $0 and sold $320.5K worth of shares.
Robin Swartz's most recent insider trade was on Feb 24, 2026, when they sold 6,458 shares at $3.77 per share.
Robin Swartz serves as Executive at Voyager Therapeutics, Inc. (VYGR). They have executed 15 insider transactions totaling $320.5K over their tenure at the company.
Robin Swartz holds the position of Executive at Voyager Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Robin Swartz has shown a selling trading pattern, with $0 in total purchases and $320.5K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robin Swartz was on Mar 15, 2023, when they sold $126.1K worth of VYGR shares. This transaction involved 15,373 shares at $8.20 per share.
Robin Swartz currently owns 199,738 shares of Voyager Therapeutics, Inc. (VYGR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robin Swartz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robin Swartz has 15 Form 4 filings on record as an insider at Voyager Therapeutics, Inc..
Set alerts for Robin Swartz and 40,000+ other insiders.